Squarepoint Ops LLC Rubius Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.79 - $5.98 $128,499 - $972,688	162,657 New	162,657 $138,000
Q1 2022 May 16, 2022	SELL	$4.25 - $10.4 $183,247 - $448,416	-43,117 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.68 - $17.74 $417,372 - $764,895	43,117 New	43,117 $417,000
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $308,000 - $453,425	-17,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $45,076 - $57,570	2,025 Added 13.09%	17,500 $427,000
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $47,959 - $191,419	-5,980 Reduced 27.87%	15,475 $410,000
Q4 2020 Feb 16, 2021	SELL	$4.23 - $8.73 $136,438 - $281,586	-32,255 Reduced 60.05%	21,455 $163,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $6.25 $113,032 - $151,925	24,308 Added 82.67%	53,710 $269,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $6.88 $117,902 - $202,285	29,402 New	29,402 $176,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.